Cutaneous sarcoidosis therapy updated - 12/08/11
Doi : 10.1016/j.jaad.2006.06.019
Christy Badgwell, MD, Ted Rosen, MD ⁎ 
From the Dermatology Department, Baylor College of Medicine, and Houston Veterans Affairs Medical Center
Correspondence to: Ted Rosen, MD, 2815 Plumb, Houston, TX 77005.Houston, Texas
Abstract |
The widely accepted standard therapy for cutaneous sarcoidosis includes corticosteroids, antimalarials, and methotrexate. However, a better understanding of the basic immunopathogenic properties of sarcoidosis has elucidated a number of steps critical to the persistence and progression of disease that may be vulnerable to treatment by targeted therapy. This article reviews both standard and newer therapeutic options for cutaneous sarcoidosis.
Il testo completo di questo articolo è disponibile in PDF.Abbreviations used : APC, FDA, ICAM-1, IFN-γ, IL, MGC, TNF⍺
Mappa
| Funding sources: None. Conflicts of interest: None identified. Reprints not available from the authors. |
© 2007
American Academy of Dermatology, Inc.. Pubblicato da Elsevier Masson SAS. Tutti i diritti riservati.
Vol 56 - N° 1
P. 69-83 - gennaio 2007 Ritorno al numero
Articolo precedente
- Topical imiquimod in the treatment of infantile hemangiomas: A retrospective study
- Nhung T.C. Ho, Perla Lansang, Elena Pope
- What’s new online?
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.
Già abbonato a @@106933@@ rivista ?